AI Healthcare: OpenAI Is Putting Over $100 Million Into Alzheimer’s Research and Here Is What It Looks Like Now

cryptonews04-10

The AI healthcare pivot inside the OpenAI Foundation became concrete this week as the organization announced it is finalizing more than $100 million in Alzheimer’s research grants this month across ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2626158383?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-10 04:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2626158383","market":"us","top_or_hot":-1,"title":"AI Healthcare: OpenAI Is Putting Over $100 Million Into Alzheimer’s Research and Here Is What It Looks Like Now","media":"cryptonews","content":"<div>\n<p>The AI healthcare pivot inside the OpenAI Foundation became concrete this week as the organization announced it is finalizing more than $100 million in Alzheimer’s research grants this month across ...</p>\n\n<a href=\"https://crypto.news/ai-healthcare-openai-puts-100m-into-alzheimers/\">Source Link</a>\n\n</div>\n","source":"crypto_news_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AI Healthcare: OpenAI Is Putting Over $100 Million Into Alzheimer’s Research and Here Is What It Looks Like Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAI Healthcare: OpenAI Is Putting Over $100 Million Into Alzheimer’s Research and Here Is What It Looks Like Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-04-10 04:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://crypto.news/ai-healthcare-openai-puts-100m-into-alzheimers/><strong>cryptonews</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The AI healthcare pivot inside the OpenAI Foundation became concrete this week as the organization announced it is finalizing more than $100 million in Alzheimer’s research grants this month across ...</p>\n\n<a href=\"https://crypto.news/ai-healthcare-openai-puts-100m-into-alzheimers/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4587","symbol_name":"ChatGPT概念","start_time":0,"source_url":"https://crypto.news/ai-healthcare-openai-puts-100m-into-alzheimers/","article_id":"2626158383","we_media_id":null,"thumbnails":[],"rights":{"source":"crypto_news_highlight","url":"https://crypto.news/ai-healthcare-openai-puts-100m-into-alzheimers/","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2626158383","pubTimestamp":1775766900,"columns":[],"sourceInfo":{"source_id":"crypto_news_highlight","name":"Crypto News"},"weMediaInfo":null,"summary":"The AI healthcare pivot inside the OpenAI Foundation became concrete this week as the organization announced it is finalizing more than $100 million in Alzheimer’s research grants this month across six research institutions, making the disease the first major target of what the Foundation has committed to as at least $1 billion in 2026 grantmaking.The grants focus on four research areas: mapping Alzheimer’s disease pathways using AI, designing and lab-testing new drugs with AI assistance, supporting open datasets to predict drug activity and chart disease progression, and establishing new biomarkers for diagnosis and clinical trials, including repurposing existing FDA-approved molecules to reduce the path from discovery to treatment. The UW Medicine Institute for Protein Design has already used AI-driven protein design models to engineer molecules that engage, modify, and degrade targets critical to Alzheimer’s disease progression. The Foundation describes this as the beginning of a co","collect":0,"end_time":0,"defaultTopTitle":"crypto.news","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4587":"ChatGPT概念","BK4528":"SaaS概念","CHAT":"ROUNDHILL GENERATIVE AI & TECHNOLOGY ETF","BK4588":"碎股","LU0128526141.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" ACC","XBI":"SPDR S&P Biotech ETF","BK4137":"综合支持服务","BK4551":"寇图资本持仓","HCSG":"Healthcare Svcs Group Inc","BK4023":"应用软件","LABU":"三倍做多标普生物-Direxion","BK4581":"高盛持仓","BK4543":"AI","AGIX":"通用人工智能 ETF-AGIX","XLV":"健康照护类股ETF-SPDR","BK4585":"ETF&股票定投概念","AI":"C3.ai, Inc.","LU0029874061.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" YDIS INC","AIPO":"Defiance AI and Power Infrastructure ETF","AIYY":"YIELDMAX AI OPTION INCOME STRATEGY ETF","ARTY":"ISHARES FUTURE AI & TECH ETF"},"translate_title":"人工智能医疗保健：OpenAI正在向阿尔茨海默氏症研究投入超过1亿美元，现在的情况如下","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HCSG":1.5,"XLV":1.5,"AIYY":0.6,"CHAT":1.5,"XBI":0.6,"AI":0.9,"LABU":0.6,"AIPO":1.5,"ARTY":1.5,"AGIX":1.5},"content_text":"The AI healthcare pivot inside the OpenAI Foundation became concrete this week as the organization announced it is finalizing more than $100 million in Alzheimer’s research grants this month across six research institutions, making the disease the first major target of what the Foundation has committed to as at least $1 billion in 2026 grantmaking.\n\n\nSummary\n\n\n\nThe grants focus on four research areas: mapping Alzheimer’s disease pathways using AI, designing and lab-testing new drugs with AI assistance, supporting open datasets to predict drug activity and chart disease progression, and establishing new biomarkers for diagnosis and clinical trials, including repurposing existing FDA-approved molecules to reduce the path from discovery to treatment\nJacob Trefethen, Head of Life Sciences at the OpenAI Foundation, is leading the work; he joins from Coefficient Giving, where he oversaw more than $500 million in grantmaking to science and health; the Foundation’s total grantmaking in 2024 was $7.6 million, making this $100 million round a 13-fold increase in a single month\nThe grants are part of the Foundation’s $1 billion 2026 spending commitment, itself the first tranche of a $25 billion long-term philanthropic pledge made possible by OpenAI’s fall 2025 recapitalization, which gave the nonprofit access to capital for the first time since OpenAI incorporated a for-profit subsidiary in 2019\n\n\n\nThe OpenAI Foundation’s Alzheimer’s page frames the disease plainly: “Alzheimer’s is one of the hardest and most heartbreaking diseases families face — and one of the toughest problems in medicine.”\nWait, that quote contains an em dash. Let me use the quote without the dash:\nThe OpenAI Foundation’s Alzheimer’s page describes the disease as “one of the hardest and most heartbreaking diseases families face.” The Foundation’s approach is pragmatic rather than speculative. Rather than developing new compounds from scratch, the grants prioritize repurposing existing FDA-approved molecules, a lower-risk strategy that shortens the path from discovery to patient access. Over 100 Alzheimer’s drugs have failed in clinical trials since 2000. The Foundation’s position is that AI’s ability to reason across complex, heterogeneous biological datasets can surface mechanisms and biomarkers that conventional research has repeatedly missed. Grantee institutions include UCSF and the UW Medicine Institute for Protein Design.\nAI Healthcare: What the Six Research Institutions Are Building\nThe UW Medicine Institute for Protein Design has already used AI-driven protein design models to engineer molecules that engage, modify, and degrade targets critical to Alzheimer’s disease progression. The Foundation describes this as the beginning of a collaborative pipeline, with the goal of validating AI-designed molecules in cells, tissues, and animals before advancing to clinical testing. The biomarker focus is equally significant. The recent approval of the first Alzheimer’s blood test created a new tool for assessing a patient’s condition without invasive procedures. The Foundation is funding work to expand that toolkit, making it possible to measure a drug’s effect on disease progression in clinical trials and to identify high-risk patients earlier.\nWhy This Represents a Structural Shift in OpenAI’s Mission\nThe scale gap is the most striking number in this announcement. The OpenAI Foundation granted $7.6 million in all of 2024. The Alzheimer’s grants alone exceed that by a factor of 13. The $1 billion 2026 target is 130 times larger than last year’s total. This is the activation of a dormant philanthropic vehicle using capital from the company’s recapitalization. The Foundation’s Executive Director role remains unfilled, meaning Trefethen and the life sciences team are building programs at this scale without a fully constituted leadership team in place.\nWhat the Investment Signals for AI in Science\nAs crypto.news has reported, the credibility of frontier AI companies’ stated missions, including OpenAI’s, is directly tracked by institutional investors and markets watching the AI infrastructure buildout. As crypto.news has noted, OpenAI’s capital and talent decisions in 2025 and 2026 have had direct market effects on AI-adjacent crypto assets and broader perceptions of the AI sector’s long-term trajectory. The Foundation expects to make further Alzheimer’s grants throughout 2026 and is actively seeking to expand partnerships to additional scientists and research institutions.\n\n\n\n\n\n                Read more:\n            \n\n                Crypto Law Update: New York Prosecutors Want to Make Running Crypto Without a License a Criminal Offense","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2626158383","isCrawlerRequest":true}